1403602-33-4
1403602-33-4
Chemical Structure
GSK951A
- CAS. Nr.: 1403602-33-4
- Formula:C24H23F3N4O3
- Molecular Weight:472.46
IUPAC Name: (5R,7S)-N-(benzo[d][1,3]dioxol-5-ylmethyl)-5-(4-ethylphenyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
InChIKey: AGTNDMNRULIWGD-NQIIRXRSSA-N
SMILES: O=C(C1=C2N(N=C1)[C@@H](C[C@@](C3=CC=C(C=C3)CC)([H])N2)C(F)(F)F)NCC4=CC=C(OCO5)C5=C4
Biological Activity: GSK951A is a THPP analogue. GSK951A inhibits mycolic acid biosynthesis. GSK951A combines potency in culture with in vivo activity and lack of cytotoxicity[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK951A | GSK951A is a THPP analogue. GSK951A inhibits mycolic acid biosynthesis. GSK951A combines potency in culture with in vivo activity and lack of cytotoxicity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
